New realities of phase I clinical trials in the era of immuno-oncology: the durvalumab experience

Autor:	Shaad Essa Abdullah, E. Oflazoglu, Jean-Charles Soria, M.M. Dar
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty Durvalumab Clinical Trials Phase I as Topic business.industry MEDLINE Phases of clinical research Antibodies Monoclonal Hematology Medical Oncology Clinical trial Internal medicine Neoplasms Medicine Humans business
Zdroj:	Annals of oncology : official journal of the European Society for Medical Oncology. 30(12)
ISSN:	1569-8041
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db02c76a1d9d25c9390dd7f4333481a3 https://pubmed.ncbi.nlm.nih.gov/31589295 Zobrazit plný text záznamu